Randomized controlled trial of consensus interferon with or without zinc for chronic hepatitis C patients with genotype 2

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

206

HTML

1191

Figures (1-2)

173

Tables (1-5)

152

Sum=1722

Feb 14, 2006 (publication date) through Nov 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Feb 14, 2006; 12(6): 945-950
Published online Feb 14, 2006. doi: 10.3748/wjg.v12.i6.945

Table 3 Logistic regression model of predictors of response to CIFN treatment

Variables	Odds ratio (95%Confidence Interval)
Zinc supplementation (regimen B vs. A)	0.254 (0.033-1.948)	0.1873
BMI (<23.4 vs. ≥23.4)	1.245 (0.162-9.579)	0.8330
Staging (0-1 vs. 2-3)	0.213 (0.024-1.877)	0.1635
pretreatment HCV-RNA (<400 vs. ≥400)	0.104 (0.011-0.951)	0.0450
Week of HCV-RNA clearance (<8 vs. ≥8)	0.106(0.005-2.399)	0.1584
pretreatment ALT (<107 vs. ≥107)	13.709 (0.960-195.749)	0.1873

Citation: Suzuki H, Sato K, Takagi H, Kanda D, Sohara N, Kakizaki S, Nakajima H, Otsuka T, Nagamine T, Mori M. Randomized controlled trial of consensus interferon with or without zinc for chronic hepatitis C patients with genotype 2. World J Gastroenterol 2006; 12(6): 945-950
URL: https://www.wjgnet.com/1007-9327/full/v12/i6/945.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i6.945